Sleep is integral to life 1 . Although insufficient or disrupted sleep increases the risk of multiple pathological conditions, including cardiovascular disease 2 , we know little about the cellular and molecular mechanisms by which sleep maintains cardiovascular health. Here we report that sleep regulates haematopoiesis and protects against atherosclerosis in mice. We show that mice subjected to sleep fragmentation produce more Ly-6C high monocytes, develop larger atherosclerotic lesions and produce less hypocretin-a stimulatory and wake-promoting neuropeptide-in the lateral hypothalamus. Hypocretin controls myelopoiesis by restricting the production of CSF1 by hypocretinreceptor-expressing pre-neutrophils in the bone marrow. Whereas hypocretin-null and haematopoietic hypocretin-receptor-null mice develop monocytosis and accelerated atherosclerosis, sleepfragmented mice with either haematopoietic CSF1 deficiency or hypocretin supplementation have reduced numbers of circulating monocytes and smaller atherosclerotic lesions. Together, these results identify a neuro-immune axis that links sleep to haematopoiesis and atherosclerosis.
(Extended Data Fig. 1j-l) . To understand the influence of sleep on circadian leukocyte migration to tissues 10, 11 , we profiled leukocytes in various organs at ZT3 and ZT14. Both control and SF mice had elevated Ly-6C high monocyte and neutrophil levels in various tissues during the dark period, and these increases were higher in SF mice (Extended Data Fig. 2 ). These observations align with human studies that have linked sleep curtailment or interruption with leukocyte numbers 12, 13 .
Next, we focused on haematopoiesis. In Apoe −/− mice, sleep fragmentation increased proliferation of lineage (Lin) − Kit + Sca1 + (LSK) haematopoietic progenitors in the bone marrow, and this increase corresponded to an approximately twofold-higher number of bone marrow LSK cells ( Fig. 1e ) and other progenitor subsets (Extended Data Fig. 3a ). The spleens of SF mice contained more LSK cells and granulocyte-macrophage progenitors, which indicates heightened extramedullary haematopoiesis (Extended Data Fig. 3b ). Sleep fragmentation promoted myelopoiesis not only in Apoe −/− mice that were fed a high-fat diet, but also in C57BL/6 mice fed a chow diet (Extended Data Fig. 3c ). Together, these data show that sleep fragmentation boosts myeloid-biased haematopoiesis.
Mice subjected to sleep fragmentation had normal bone structure (Extended Data Fig. 4a , b) and leukocytosis persisted even after prolonged treatment with antibiotics (Extended Data Fig. 4c ), suggesting that enhanced myelopoiesis was not driven by either physical alterations to the bone or the microbiome, respectively. Because stress activates the sympathetic nervous system, which can heighten haematopoiesis 14 , we wondered whether sleep-fragmentation-induced myelopoiesis similarly depended on activation of the sympathetic nervous system, but found no evidence for such a mechanism (Extended Data Fig. 5a-d ). Nevertheless, SF mice were more anxious (Extended Data Fig. 5e-g) , which demonstrates that mice do not easily habituate to sleep fragmentation.
We then focused on the hypothalamus and, specifically, on expression of transcripts that encode sleep-regulating proteins (Extended Data Fig. 5h-j) . Sleep fragmentation decreased expression of hypocretin (Hcrt, also known as orexin) in the hypothalamus (Fig. 1f-h) , correlating with reduced levels of the isoform hypocretin-1 in plasma and bone marrow ( Fig. 1i ). Hypothalamic hypocretin reduced gradually and correlated inversely with leukocytosis (Extended Data Fig. 6a ). We did not see alterations in dynorphin, a co-transmitter of hypocretin 15 (Extended Data Fig. 6b -e) or any evidence for death of hypocretinproducing neurons (Extended Data Fig. 6f ), which suggests that specific repression of hypocretin occurred, potentially mediated by neuropeptide Y 16 (Extended Data Fig. 5h ). Furthermore, sleep recovery following sleep fragmentation restored hypothalamic hypocretin content and normalized myelopoiesis (Extended Data Fig. 6g-i) . These data intrigued us, because hypocretin mediates metabolism, sleep and appetite 17 , and autoimmune destruction of hypocretin neurons causes Letter reSeArCH narcolepsy 18 and a pro-inflammatory immune signature 19 . In keeping with the function of hypocretin in the promotion of appetite, SF mice consumed less food than controls (Extended Data Fig. 5k ).
In humans, reduced plasma hypocretin is associated with risk of myocardial infarction 20 , heart failure 21 and obesity 22 . Similarly, studies suggest that patients with narcolepsy have heightened risk of heart disease 23 . In mice, deleting hypocretin severely fragments sleepwake cycles, causes cataplexy and promotes diet-induced obesity 24, 25 . Moreover, deleting the hypocretin receptor-2 worsens healing after myocardial infarction 21 . We therefore profiled leukocytes in hypocretinnull (Hcrt −/− ) mice and found a higher number of Ly-6C high monocytes and neutrophils in the blood, spleen and bone marrow relative to wild-type controls (Fig. 2a, b and Extended Data Fig. 7 ). Rhythmicity analysis of Hcrt −/− mouse blood revealed that Ly-6C high monocytes and neutrophils had elevated circadian amplitudes (1.8 ± 0.32 × 10 5 compared to 3.7 ± 0.55 × 10 5 , in wild-type and Hcrt −/− mice, respectively, P = 0.02, for Ly-6C high monocytes and 4.1 ± 0.69 × 10 5 compared to 8.1 ± 0.11 × 10 5 , in wild-type and Hcrt −/− mice, respectively, P = 0.03, for neutrophils), but that the period and phase were unchanged. Bone marrow from Hcrt −/− mice had more haematopoietic progenitors along with increased proliferation of LSK cells ( Fig. 2c and Extended Data Fig. 7) . As in the SF mice, accelerated haematopoiesis in hypocretindeficient mice did not appear to depend on the microbiome (Extended Data Fig. 4d ). These results suggest that sleep regulates haematopoiesis through hypocretin.
Next, we tested whether hypocretin can affect haematopoiesis and atherosclerosis. We found that the hypothalamus produced nearly all of the hypocretin (Extended Data Fig. 8a, b ). Sixteen weeks of sleep fragmentation did not alter hypocretin production in the bone and bone marrow (Extended Data Fig. 8c ), which indicates that the hypothalamus was the relevant source affected by sleep. Indeed, we found substantial concentrations of the neuropeptide in the cerebrospinal fluid, plasma and bone marrow fluid of wild-type but not Hcrt −/− mice, and we detected high levels of HCRT-1 in the plasma and bone marrow fluid of Hcrt −/− mice after injecting HCRT-1 into the cerebrospinal fluid of the cisterna magna (Extended Data Fig. 8d, e ). Consequently, we generated chimeric mice lacking hypocretin production in either the non-haematopoietic compartment (including the hypothalamus) or haematopoietic cells (Fig. 2d ), and found heightened haematopoiesis in Hcrt −/− mice containing wild-type bone marrow cells ( Fig. 2e ). We also placed Hcrt −/− mice in parabiosis with wild-type mice ( Fig. 2f ), noting that wild-type-partnered Hcrt −/− mice had suppressed haematopoiesis compared to Hcrt −/− -partnered Hcrt −/− mice (Fig. 2g ). These data suggest that hypothalamus-produced hypocretin can enter the circulation to affect haematopoiesis in the distal bone marrow 26, 27 . To determine whether hypocretin deficiency aggravates atherosclerosis, we generated Hcrt −/− Apoe −/− mice, which had larger lesions with more aortic leukocytes than did Apoe −/− controls ( Fig. 2h, i) .
Having identified a link between hypocretin, haematopoiesis and atherosclerosis, we examined the underlying mechanism. 
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Although hypocretin receptor-1 (Hcrtr1) and hypocretin receptor-2 (Hcrtr2) expression was the highest in the hypothalamus, we detected Hcrtr1 in multiple tissues, including the bone marrow (Extended Data Fig. 8f , g). However, adding hypocretin to granulocyte-macrophage colony-forming cultures had no effect on haematopoiesis in vitro (Extended Data Fig. 8h ). We therefore sorted 14 different cell types from the bone marrow and found that neutrophils-but not other cells-expressed Hcrtr1 mRNA ( Fig. 3a ) and HCRTR1 protein (Extended Data Fig. 8i ). We next sorted neutrophils by maturation stage 28 (Extended Data Fig. 9a ) and found that pre-neutrophils expressed Hcrtr1 most abundantly ( Fig. 3b ). Using knockout-reporter Hcrtr1 GFP/GFP mice 29 , we identified a subset of bone-marrow-resident MDPs, monocyte-dendritic cell progenitors. b, Hcrtr1 mRNA expression in bone marrow and blood neutrophil populations (n = 4 mice). c, Flow cytometry plot of HCRTR1 + pre-neutrophils in the bone marrow of wildtype mice transplanted with Hcrtr1 GFP/GFP bone marrow. d, Csf1 expression in sorted bone marrow cells (for Ly-6C high monocytes, B cells and other leukocytes, n = 3 mice; for neutrophils and CD45 − cells, n = 5 mice). e, Csf1 expression in sorted bone marrow neutrophil populations (n = 4 mice). f, CSF1 production by pre-neutrophils sorted from wild-type mice and exposed to lipopolysaccharides (LPS) and/or HCRT-1 (for untreated and HCRT-1, n = 4 mice per group; for LPS, and LPS and HCRT-1, n = 6 mice per group). *P < 0.05, ***P < 0.001, one-way ANOVA. g, CSF1 production by pre-neutrophils sorted from wild-type and Hcrt −/− mice (n = 4 mice per group). h, Concentration of CSF1 in the bone marrow of Apoe −/− SF mice and Hcrt −/− mice (n = 4 Apoe −/− mice; n = 6 Apoe −/− SF mice; n = 4 wild-type mice; n = 7 Hcrt −/− mice). i, Quantification of blood Ly-6C high monocytes over 24 h in WT;bmHcrtr1 GFP/GFP mice (n = 3 per group). ***P < 0.001, two-way ANOVA. j, Quantification of bone marrow LSK cells and proliferation of LSK cells in wild-type mice transplanted with wild-type or Hcrtr1 GFP/GFP bone marrow cells (for LSK cells per leg, n = 5 mice per group; for proliferation assays, n = 4 WT;bmWT mice and n = 5 WT;bmHcrtr1 GFP/GFP mice). k, Concentration of CSF1 in the bone marrow of wild-type mice transplanted with wildtype or Hcrtr1 GFP/GFP bone marrow cells (n = 4 WT;bmWT mice; n = 5 WT;bmHcrtr1 GFP/GFP mice). l, Images of cross-sections of aortic roots stained with oil red O and quantification of atherosclerosis in Ldlr −/− mice transplanted with wild-type or Hcrtr1 GFP/GFP bone marrow cells and fed a high-cholesterol diet for 12 weeks (n = 8 Ldlr −/− ;bmWT mice ; n = 9 Ldlr −/− ;bmHcrtr1 GFP/GFP mice). Data are mean ± s.e.m., *P < 0.05, **P < 0.01, ***P < 0.001, two-tailed Mann-Whitney U-tests unless otherwise indicated. ND, not detected.
pre-neutrophils as GFP + and thus able to express the receptor ( Fig. 3c and Extended Data Fig. 9b ).
The observation that bone marrow CXCR4 + CXCR2 − pre-neutrophils expressed Hcrtr1 was notable, because these cells reside in close proximity to haematopoietic progenitors 28 . Moreover, neutrophils produce substantial amounts of colony stimulating factor-1 (CSF1), which promotes bone marrow myeloid-biased haematopoiesis 30 (Fig. 3d ). In part because pre-neutrophils sorted from wild-type mice expressed less Csf1 compared to mature neutrophils ( Fig. 3e ), we tested whether hypocretin can control haematopoiesis through HCRTR1 + pre-neutrophilderived CSF1. In vitro, hypocretin limited the capacity of pre-neutrophils to produce CSF1 in response to lipopolysaccharides ( Fig. 3f and Extended Data Fig. 9c ). Ex vivo, pre-neutrophils and neutrophils sorted from Hcrt −/− mice contained more Csf1 mRNA and secreted more CSF1 protein than cells sorted from wild-type mice ( Fig. 3g and Extended Data Fig. 9d ). In vivo, we found increased levels of CSF1 in the bone marrow of Hcrt −/− mice and Apoe −/− mice subjected to sleep fragmentation ( Fig. 3h ). Indeed, sleep fragmentation increased bone marrow CSF1 production without substantially changing the expression of other growth factors (Extended Data Fig. 9e ).
Because bone marrow non-haematopoietic cells do not express HCRTR1 ( Fig. 3a ) but produce CSF1 (Fig. 3d) , we asked whether hypocretin-mediated control of leukocyte-derived CSF1 is important. First, we lethally irradiated wild-type mice and transplanted them with bone marrow cells from either wild-type or Hcrtr1-knockout reporter (Hcrtr1 GFP/GFP ) mice. Chimaeras with Hcrtr1 GFP/GFP bone marrow developed monocytosis ( Fig. 3i ), along with an increased number of LSK cells, increased proliferation of LSK cells ( Fig. 3j ) and increased levels of CSF1 in the bone marrow ( Fig. 3k ). Second, we transplanted Ldlr −/− mice with Hcrtr1 GFP/GFP bone marrow and noted augmented atherosclerosis ( Fig. 3l ). Third, we lethally irradiated wild-type or Hcrt −/− mice and transplanted them with bone marrow cells from either wild-type or Csf1 −/− mice (Extended Data Fig. 10a ). As expected, wild-type mice had relatively few Ly-6C high monocytes regardless of bone marrow source. However, whereas Hcrt −/− mice reconstituted with wild-type bone marrow cells developed leukocytosis, Hcrt −/− mice reconstituted with Csf1 −/− bone marrow cells had relatively few Ly-6C high monocytes, limited haematopoietic progenitors and proliferation, and reduced concentrations of CSF1 (Extended Data Fig. 10b-f ). Notably, neutrophil numbers remained high in Hcrt −/− mice reconstituted with Csf1 −/− bone marrow, which indicates that neutrophilia in Hcrt −/− mice was not directly related to the interactions between HCRT and leukocyte control of CSF1, an observation we confirmed in wild-type (WT) mice reconstituted with bone marrow (bm) from Hcrtr1 GFP/GFP mice (hereafter WT;bmHcrtr1 GFP/ GFP mice) (Extended Data Fig. 9f ). Fourth, we induced atherogenesis in wild-type and Hcrt −/− chimaeras reconstituted with either wildtype or Csf1 −/− bone marrow by overexpressing PCSK9 and feeding the mice a high-cholesterol diet. We found that Hcrt −/− ;bmWT mice developed larger lesions than Hcrt −/− ;bmCsf1 −/− mice (Extended Data Fig. 10g-i) . These data agree with the hypothesis that hypocretin controls monocytosis and atherosclerosis by mediating CSF1 production by pre-neutrophils. Finally, we sought to explore the role of hypocretin in atherosclerosis and sleep fragmentation. We generated Ldlr −/− mice with either wildtype or Csf1 −/− bone marrow, and subjected the chimaeras to sleep fragmentation (Fig. 4a ). Ldlr −/− mice with wild-type bone marrow that were subjected to sleep fragmentation developed monocytosis through increased haematopoiesis, increased proliferation of LSK cells and increased levels of CSF1 in the bone marrow-processes that together led to bigger atherosclerotic lesions-whereas the absence of bone marrow-derived CSF1 reduced these parameters in SF mice ( Fig. 4b-e ). Moreover, we delivered hypocretin to the periphery of Apoe −/− mice subjected to sleep fragmentation (Fig. 4f ). Compared to controls, Apoe −/− mice subjected to sleep fragmentation that received hypocretin had fewer monocytes and neutrophils in the blood (Fig. 4g) , reduced proliferation and a reduction in the number of LSK cells in the bone marrow ( Fig. 4h) , lower levels of CSF1 in the bone marrow ( Fig. 4i ) and smaller lesions (Fig. 4j ). These results demonstrate that hypocretin loss during sleep fragmentation aggravates haematopoiesis and atherosclerosis.
Our data indicate that sleep protects against atherosclerosis. Undisturbed sleep maintains proper hypothalamic release of hypocretin, which limits pre-neutrophil CSF1 in the bone marrow, thereby curtailing haematopoiesis and atherosclerosis. This neuro-immune axis directly connects sleep to immune function and cardiovascular disease (Fig. 4k ).
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MEthodS
Animals. Wild-type C57BL/6J, Apoe tm1Unc (Apoe −/− ), Ldlr tm1Her /J (Ldlr −/− ) and Csf1 op (Csf1 −/− ) mice were purchased from The Jackson Laboratory. Hcrt −/− mice 31 were provided by T. Scammell (Department of Neurology, Beth Israel Deaconess Medical Center) and bred in-house. Hcrtr1 GFP/GFP mice 29, 32 were provided by A. Vassalli (Department of Physiology, University of Lausanne). Stromal cell Nestin-GFP mice 33, 34 , Lepr-cre-Rosa26-eYFP mice 35, 36 and OCN-GFP topaz reporter mice 37 were provided by D. Scadden (Department of Stem Cell and Regenerative Biology, Harvard University and the Center for Regenerative Medicine, Massachusetts General Hospital). Genotyping for each strain was performed as described on the Jackson Laboratory website. Age-and sex-matched animals were used starting at 8-12 weeks of age. For experiments involving Apoe −/− and Ldlr −/− mice, female mice were used. For all other experiments, both male and female mice were used. All mice were group-housed on a 12:12-h light:dark cycle at 22 °C with free access to food and water. Where appropriate, animals were randomly assigned to interventions. Experiments were performed in a blinded fashion. All protocols were approved by the Animal Review Committee at Massachusetts General Hospital (protocol no. 2011N000035 and 2015N000044) and were in compliance with relevant ethical regulations. In vivo interventions. Diet. Apoe −/− mice were fed a high-fat diet (HFD, Harlan Teklad, TD.88137) and Ldlr −/− mice were fed a high-cholesterol diet (HCD, Research Diets, D12331). Mice were injected by intravenous injection with 5 × 10 11 U of adv-PCSK9 virus after which the mice were fed the HCD immediately after virus injection. Unless otherwise indicated, mice were fed a regular chow diet. Sleep fragmentation. For sleep fragmentation studies, mice were placed in a sleep fragmentation chamber (Lafayette Instrument) at the same time as initiation of special diet feeding. The sweep bar moved along the bottom of the cage every 2 min during the light cycle (ZT0-12). The sweep bar automatically shut off and was stationary during the dark cycle (ZT12-24). Control mice that received undisturbed sleep were placed in sleep fragmentation chambers with stationary sweep bars. For the control experiment in Extended Data Fig. 1f -h, the sweep bar moved along the bottom of the cage every 2 min during the dark cycle (ZT12-0) and automatically shut off and was stationary during the light cycle (ZT0-12).
Interventions. For studies on microbiota, mice were treated with an antibiotic cocktail (0.1% ampicillin, 0.1% metronidazole, 0.05% vancomycin and 0.1% neomycin) in drinking water for 4 weeks. Antibiotics-containing drinking water was changed weekly. For hypocretin-supplementation studies, HFD-fed Apoe −/− control and sleep fragmentation mice were implanted subcutaneously with osmotic minipumps (Alzet) 8 weeks after experiment initiation. Mice were supplemented with hypocretin-1 or saline during weeks 8 to 16 of the experiment. Mice were randomly assigned a pump containing either saline or hypocretin-1 (Sigma Aldrich) delivered at 50 nmol h −1 kg −1 . Pumps were replaced after four weeks. Parabiosis. The procedure was conducted as previously described [38] [39] [40] . In brief, age-, sex-and weight-matched animals were used and housed together for at least 14 days before surgery. The corresponding lateral aspects of each mouse were shaved, incisions were made from the forelimb joint to the hindlimb joint and the subcutaneous fascia was bluntly dissected to create 0.5 cm of free skin. Fore-and hindlimb joints were joined and the dorsal and ventral skins were approximated by continuous suture using mononylon 5.0 (Ethicon). Bone marrow transplantation. Mice were lethally irradiated (950 cGy) and reconstituted with 6 × 10 6 bone marrow cells injected intravenously to generate chimaera groups. Mice were allowed to recover for eight weeks before further manipulation. Intra-cisterna magna injection. The procedure was conducted as previously described 41 . Mice were anaesthetized and the skin of the neck was shaved and disinfected with 70% ethanol. Mice were placed in a stereotactic frame (Stoelting) to secure their heads. A skin incision was made at the back of the neck and muscle layers were retracted to expose the cisterna magna. Using a Hamilton syringe, 2 μg of hypocretin-1 dissolved in 5 μl of PBS was injected into the CSF-filled cisterna magna compartment. After injection the needle was left in place for 5 min before removal to prevent backflow. The skin of the neck was sutured closed and mice were allowed to recover. Cells. Cell collection. Peripheral blood was collected by retro-orbital bleeding and red blood cells were lysed in RBC lysis buffer (Biolegend). Aortas, lungs, livers and hearts were excised after PBS (Thermo Fisher Scientific) perfusion, minced and digested with 450 U ml −1 collagenase I, 125 U ml −1 collagenase XI, 60 U ml −1 DNase I and 60 U ml −1 hyaluronidase (Sigma-Aldrich) in PBS for 20 min (liver), 40 min (aorta) or 1 h (heart and lung) at 37 °C. Spleens were crushed through a 40-μm cell strainer and red blood cells were lysed with RBC lysis buffer. Bone marrow cells were collected by flushing bones with PBS, after which a single-cell suspension was created by passing cells through a 26-gauge needle and red blood cells were lysed with RBC lysis buffer. Total viable cell numbers were counted using trypan blue (Cellgro, Mediatech) or counting beads (Thermo Fisher Scientific). Cell sorting. Bone marrow cell suspensions were stained to identify the indicated cell populations and cells were sorted on a FACS Aria II cell sorter (BD Biosciences) directly into collection medium.
Flow cytometry. Single-cell suspensions were stained in PBS supplemented with 2% FBS and 0.5% BSA. The following monoclonal antibodies were used for flow cytometry analyses: anti-CD45 (BioLegend, clone30-F11, 103147, lot B243834), anti-CD45.1 (BioLegend, clone A20, 110708), anti-CD45.2 (BioLegend, clone 104, 109802), anti-CD3 (BioLegend, clone 17A2, 100206), anti-CD90.2 (BioLegend, clone 53-2.1, 105308, lot B260050), anti-CD19 (BioLegend, clone 6D5, 115508, lot B226581), anti-B220 (BD Biosciences, clone RA3-6B2, 553089, lot 6012954), anti-NK1.1 (BioLegend, clone PK136, 108708), anti-Ly-6G (BioLegend, clone 1A8, 127614, lot B259670), anti-Ly-6C (BioLegend, AL-21, 128006, lot B247728), anti-MHCII (BioLegend, clone M5/114.152, 107602, lot B217859), anti-F4/80 (Biolegend, clone BM8, 123114, lot B237342), anti-CD11b (BioLegend, clone M1/70, 101226, lot B238268), anti-CD115 (BioLegend, clone AFS98, 135517, lot B265220), anti-Ter119 (BioLegend, clone TER-119, 116208, lot B220899), anti-CD34 (eBioscience, clone RAM34, 11-0341-85, lot E00265-1634), anti-CD49b (BioLegend, clone DX5, 1089008, lot B258302), anti-CD11c (BioLegend, clone N418, 117310, lot B206713), anti-IL-7Rα (BioLegend, clone SB/199, 121112, lot B189668), anti-CD16/32 (BioLegend, clone 93, 101324, lot B250025), anti-CD150 (BioLegend, clone TC15-12F12.2, 115922, lot B220585), anti-Kit (BioLegend, clone 2B8, 105814, lot B252918), anti-CD135 (BioLegend, clone A2F10, 135310, lot B234045), anti-CD48 (BioLegend, clone HM48-1, 103426, lot B236445), anti-Sca1 (BioLegend, clone D7, 108126, lot B234288), anti-CD8 (BD Bioscience, clone 53-6.7, 553035, lot 2296946), anti-CD4 (BioLegend, clone GK1.5, 100428, lot B237336), anti-SiglecF (BD Pharmingen, clone E50-2440, 562680, lot 7054789), anti-CXCR4 (Invitrogen, clone 2B11, 12-9991-81, lot B251481), anti-CXCR2 (BioLegend, clone SA044G4, 149307, lot B251481), anti-BrdU (eBioscience, clone BU20A, 17-5071-42, lot 4319920). All antibodies were used in a 1:700 dilution. Viable cells were identified as unstained with Zombie Aqua (BioLegend). Cells were identified as (1) Ly-6C high monocytes (CD45 + Lin1 − CD11b + CD115 + F4/80 − Ly-6C high ), (2) 
long-term haematopoietic stem cells (CD45 + Lin2 − Kit + Sca1 + CD135 + CD150 + CD48 − ), (13) common myeloid progenitor (CD45 + Lin2 − Kit + Sca1 − CD34 + CD16/32 mid ), (14) granulocyte-macrophage progenitor (CD45 + Lin2 − Kit + Sca1 − CD34 + CD16/32 high CD115 − ), (15) monocyte-dendritic cell progenitor (CD45 + Lin2 − Kit + Sca1 − CD34 + CD16/32 high CD115 + ); for neutrophil populations (CD45 + CD3 − CD90.2 − CD19 − NK1.1 − SiglecF − CD115 − Kit low CD11b + Gr-1 + ) (16) pre-neutrophils were then separated as Kit int CXCR4 + CXCR2 − , (17) immature neutrophils as Kit − CXCR4 − CXCR2 − , and (18) mature neutrophils as Kit − CXCR4 − CXCR2 + Ly-6G + . Lineages were defined as Lin1: CD3, CD90.2, CD19, NK1.1, Ter119 and Lin2: B220, CD19, CD49b, Ter119, CD90.2, CD11b, CD11c, Ly-6G, IL-7Rα. Osteolineage cells (OCN + ) cells were identified as CD45 − Ter119 − CD31 − GFP + from the bone fraction of OCN-GFP mice. Leptin receptor (Lepr + ) cells were identified as CD45 − Ter119 − CD31 − YFP + form the bone marrow fraction of Lepr-cre-Rosa26-eYFP mice. Nestin + cells were identified as CD45 − Ter119 − CD31 − GFP + form the bone and bone marrow fraction of Nestin-GFP mice. Endothelial cells were identified as CD45 − Ter119 − CD31 + of the bone marrow fraction of Lepr-cre-Rosa26-eYFP mice. Data were acquired on a LSRII (BD Biosciences) and analysed with FlowJo (Tree Star). BrdU incorporation. To assess cell proliferation, 1 mg BrdU was injected intraperitoneally 2 h before euthanasia. A BrdU flow kit (BD Biosciences) was used to stain BrdU + cells. RNA and protein assays. PCR. Total RNA was isolated using the RNeasy Mini Kit (Qiagen) or the NucleoSpin RNA XS kit (Takara Bio) according to the manufacturer's instructions. RNase-free DNase Set (Qiagen) was used for DNase digestion during RNA purification. RNA quantity and quality were assessed by Nanodrop for RNA isolated from tissues and with the Aglient RNA 6000 Pico kit (Aglient Technologies) on the Aglient 2100 Bioanalyzer for RNA of fluorescence-activated cell sorting (FACS)-purified cells. cDNA was generated from 1 μg of total RNA per sample using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Quantitative real-time TaqMan PCR was performed using the following TaqMan primers (Applied Biosystems): Actb (Mm00607939_s1), Hcrt (Mm01964030_s1), Hcrtr1 (Mm01185776_m1), Hcrtr2 (Mm01179312_m1), Csf1 Csf3 (Mm00438334_m1) . PCR was run on a 7500 thermal cycler (Applied Biosystems). Gene expression was normalized to Actb and quantified with the ∆∆ 2 C t method. Enzyme-linked immunosorbent assay. Hypocretin-1 levels were measured using an enzyme-linked immunosorbent assay (ELISA) kit (Fujifilm Wako Chemicals) 42 and CSF1 (M-CSF) levels were measured using an ELISA kit (Boster Biologial Technology) according to the manufacturers' instructions. Bone marrow ELISAs were performed on bone marrow fluid. In brief, a small hole was made at the tips of the long bones and the marrow was spun out of the bones by centrifugation at 10,000 r.p.m. for 10 min. The supernatant fluid was collected. Western blot. Total protein was extracted from cells in RIPA lysis buffer with protease and phosphatase inhibitor cocktails. Total protein amount was quantified by Bradford assay. Then, 15 μg of protein was subjected to electrophoresis using a NuPAGE Novex Cel System (Life Technologies) and transferred to a nitrocellulose membrane using the iBlot Gel Transfer System (LifeTechnologies) according to the manufacturer's instructions. Anti-hypocretin receptor-1 antibody (ab68718, Abcam) and anti-β-actin antibody (clone 13E5, Cell Signaling) were used. Cell culture. For cell-culture experiments, cells were cultured in complete medium (RPMI-1640 supplemented with 10% FBS, 2 mM l-glutamine, 100 U ml −1 penicillin and streptomycin, 10 mM HEPES, 50 μM 2-mercaptoethanol, 1 mM sodium pyruvate and 1× nonessential amino acids) and kept in a humidified 5% CO 2 incubator at 37 °C. Neutrophils were sorted with a FACS Aria II and 5 × 10 5 cells were seeded into 48-well plates in 0.5 ml medium. Cells were then pre-incubated with 0.1 μM hypocretin-1 for 3 h followed by co-treatment with 20 ng ml −1 LPS for 3 h as indicated. Cells and medium were collected for downstream analysis. Myeloid colony-forming unit assay. Single-cell suspensions from bone marrows were prepared and 2 × 10 4 cells were plated in triplicates in complete methylcellulose medium (MethoCult GF M3534) with or without hypocretin-1 according to the manufacturer's instructions. Colony-forming units were counted after 11 days in a 5% CO 2 incubator at 37 °C. Histology and μCT. Aortas. Aortic roots were dissected and embedded in Tissue-Tek OCT compound (Sakura Finetek), frozen in 2-methylbutane (Fisher Scientific) cooled with dry ice and sectioned into 6-μm slices. To compare lesion size among the groups, sections that captured the maximum lesion area were used. To measure lesion volume, sections were collected beginning at the first appearance of the aortic valves and continuing until lesions were no longer visible. Oil-red-O (Sigma Aldrich) staining was performed to visualize lipid content and measure lesion size. Lesion size was measured using Nanozoomer 2.0RS (Hamamatsu). In brief, the lesion area was quantified by measuring the atherosclerotic plaque of the intima from the endothelial layer to the healthy medium. Brain. Whole brains were fixed in 10% formalin and embedded in paraffin for histological sectioning. Brains were sectioned coronally and 6-μm slices were collected. After deparaffinization and rehydration of the sections, antigen retrieval was performed and endogenous peroxidase activity was blocked by 3% H 2 O 2 solution in dH 2 O. Immunohistochemistry was done to stain for hypocretin + cells using an anti-hypocretin antibody (clone D6G9T, Cell Signaling) diluted in SignalStain Antibody Diluent (Cell Signaling) followed by biotinylated goat anti-rabbit IgG antibody (Vector Laboratories). The hypocretin + cells were visualized using avidin/biotin-based peroxidase system, VECTASTAIN Elite ABC-HRP Kit (Vector Laboratories) and AEC Substrate Chromogen (DAKO/Agilent). The tissues were counterstained with Harris haematoxylin (Sigma-Aldrich) and all images were captured using Nanozoomer 2.0RS (Hamamatsu). Dynorphin + cells were identified by staining with dynorphin A antibody (ab82509, Abcam) and AF488conjugated hypocretin antibody (clone D6G9T, Cell Signaling). Dynorphin + cells were detected using a biotinylated goat anti-rabbit IgG antibody and streptavidin DyLight 594 (Vector Laboratories). The fluorescence images were captured using a motorized fluorescence microscope Olympus BX63 and processed by FIJI/ ImageJ software. Apoptotic cells were investigated using the In situ Cell Death Detection Kit, TMR Red (Sigma-Aldrich) and nuclei were counterstained with DAPI (Thermo Fisher Scientific). Bone. Femurs were collected and fixed in 4% paraformaldehyde overnight and then scanned by μCT at the MGH Center for Skeletal Research Core (NIHP30AR066261). After scanning, femurs were decalcified in 0.375 M EDTA in PBS for 10 days before paraffin-embedding. Sections were cut and stained with anti-tyrosine hydroxylase antibody (Millipore, AB152). Behaviour phenotyping. Open field test. Mice were individually placed in a white box (50 cm × 50 cm) for 5 min with ambient lighting and videos were recorded. The time the mouse spent within 5 cm of the edge of the box was quantified.
Light-dark box test. Mice were placed in a box in which half the box (25 cm × 25 cm) was black and blocked from light, while the other half was white and exposed to ambient lighting. A dividing wall with a small hole separated the two halves of the box but allowed mice to move freely between the two halves. Videos were recorded for 5 min and the time the mice spent in the white box was quantified. Y-maze. Mice were allowed to explore two arms of the Y-maze for 5 min before being returned to their home cage. Twenty minutes later, mice were returned to the Y-maze and allowed to explore all three arms for 5 min while being recorded. The time spent in the new arm was quantified. Quantification of behavioural phenotypes was done with ImageJ software. Statistics. Results are shown as mean ± s.e.m. Statistical tests included unpaired, two-tailed non-parametric Mann-Whitney U-tests (when Gaussian distribution was not assumed). For multiple comparisons, a non-parametric multiple-comparisons test comparing the mean rank of each group (when Gaussian distribution was not assumed) was used, or one-or two-way ANOVAs followed by Turkey's test were used. To analyse circadian rhythmicity, cosinor analysis was performed with the following equation 43 : Y = baseline + amplitude × cos(frequency × X + phaseshift). P values of 0.05 or less were considered to denote significance. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. 
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Extended Data Fig. 3 | Sleep-mediated haematopoiesis and extramedullary haematopoiesis. a, Gating strategy and quantification of haematopoietic progenitor cells at ZT3 in the bone marrow (n = 10 Apoe −/− mice, except for GMPs, n = 11 mice; n = 10 Apoe −/− SF mice, except MPP3 and MPP4, n = 9 mice). LtHSCs, long-term haematopoietic stem cells; StHSC, short-term haematopoietic stem cells. b, Gating strategy and quantification of haematopoietic progenitor cells at ZT3 in the spleen (n = 9 Apoe −/− mice, except CMPs, n = 10 mice; n = 9 Apoe −/− SF mice). c, C57BL/6 wild-type mice that were fed a regular chow diet were subjected to sleep fragmentation for 16 weeks after which Ly-6C high monocytes, neutrophils and LSK cells were quantified at ZT3 (n = 8 wildtype mice, except n = 9 mice for spleen Ly-6C high monocytes, n = 5 mice for bone marrow neutrophils, n = 10 mice for bone marrow LSK cells; n = 4 wild-type SF mice, except n = 9 mice for bone marrow LSK cells). Data are mean ± s.e.m., *P < 0.05, **P < 0.01, ***P < 0.001, two-tailed Mann-Whitney U-tests. Fig. 5 | Sleep fragmentation does not activate the peripheral sympathetic nervous system but has effects on hypothalamic gene transcription and food consumption. a, Plasma corticosterone levels in Apoe −/− mice and Apoe −/− mice after 16 weeks of sleep fragmentation at ZT3 and ZT14 (n = 4 mice per group, except n = 5 Apoe −/− mice at ZT3). b, Systolic and diastolic blood pressure at ZT3 (n = 4 mice per group). c, Immunohistochemical analysis and quantification of tyrosine hydroxylaze (TH) staining in the bone marrow of Apoe −/− mice, Apoe −/− SF mice and Apoe −/− mice subjected to 3 weeks of chronic variable stress (n = 4 Apoe −/− mice; n = 4 Apoe −/− SF mice; n = 3 Apoe −/− stressed mice). d, Quantification at ZT3 of blood Ly-6C high monocytes and neutrophils, bone marrow LSK cells and proliferation in Apoe −/− mice and Apoe −/− SF mice after antagonism of the β3 receptor for 4 weeks (n = 3 Apoe −/− mice treated with β3 blocker; n = 4 Apoe −/− SF mice treated with β3 blocker). e, Quantification of time in outer zone during open field test (n = 9 Apoe −/− mice; n = 8 Apoe −/− SF mice). f, Quantification of time spent in light box during light-dark box test (n = 6 per group). g, Quantification of time in new arm during Y-maze test (n = 8 Apoe −/− mice; n = 5 Apoe −/− SF mice). h, Analysis of neuropeptide expression in the hypothalamus at ZT3 (n = 5 Apoe −/− mice, except n = 6 for Pmch, Tph2, Gad1and Npy; n = 5 Apoe −/− SF mice, except n = 4 for Npy). i, Neuropeptide receptor expression in the hypothalamus at ZT3 (n = 6 Apoe −/− mice, except Hcrtr1, n = 10 mice; n = 5 Apoe −/− SF mice, except Hcrtr2, n = 6 mice). j, Circadian gene expression in the hypothalamus at ZT3 and ZT14 (n = 3 Apoe −/− mice; n = 4 Apoe −/− SF mice). k, Mouse food consumption during the course of sleep fragmentation (n = 4 Apoe −/− mice at ZT3, except n = 6 Apoe −/− mice on HFD for 16 weeks at ZT3; n = 4 Apoe −/− SF mice at ZT3, except n = 6 Apoe −/− SF mice on HFD for 16 weeks at ZT3; n = 5 Apoe −/− mice at ZT14, except n = 4 Apoe −/− mice on HFD for 10 weeks at ZT14 and n = 6 Apoe −/− mice on HFD for 16 weeks at ZT14; n = 5 Apoe −/− SF mice at ZT14, except n = 4 Apoe −/− SF mice on HFD for 10 weeks at ZT14 and n = 6 Apoe −/− SF mice on HFD for 16 weeks at ZT14). Data are mean ± s.e.m., *P < 0.05, **P < 0.01, two-tailed Mann-Whitney U-tests. ns, not significant.
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Extended Data Fig. 6 | Hypothalamic expression of hypocretin and dynorphin. a, Hypothalamic expression of hypocretin and quantification of blood Ly-6C high monocytes and neutrophils in Apoe −/− mice after 6, 8 and 12 weeks of sleep fragmentation (for Hcrt, n = 4 Apoe −/− mice, except n = 5 for Apoe −/− mice after 12 weeks; for Hcrt, n = 4 Apoe −/− SF mice; for blood cells at 6 weeks, n = 5 mice per group; for blood cells at 8 weeks, n = 4 mice per group; for blood cells at 12 weeks, n = 9 mice per group). b, Sections of the hypothalamus stained for dynorphin and hypocretin. c, Quantification of hypothalamic dynorphin + cells per highpowered field of view (n = 5 Apoe −/− mice; n = 4 Apoe −/− SF mice, of two independent experiments). d, e, Dynorphin (Pdny) mRNA expression in the hypothalamus of SF mice (d; n = 6 Apoe −/− mice; n = 5 Apoe −/− SF mice) and Hcrt −/− mice (e; n = 4 wild-type mice; n = 5 Hcrt −/− mice). f, TUNEL staining of hypothalamic sections from Apoe −/− and Apoe −/− SF mice (representative of four biological replicates) along with a positive control of TUNEL-stained myocardium 1 day after myocardial infarction (MI) (n = 1). g-i, Apoe −/− mice were sleep-fragmented for 16 weeks then allowed to recover and sleep normally for 10 weeks. Control mice slept normally for 26 weeks. g, Analysis of hypothalamic hypocretin expression (n = 5 Apoe −/− mice; n = 4 Apoe −/− SF mice). h, Blood Ly-6C high monocytes and neutrophils (n = 5 mice per group). i, Quantification of bone marrow LSK cells and proliferation of LSK cells (n = 5 mice per group). Data are mean ± s.e.m., *P < 0.05, **P < 0.01, two-tailed Mann-Whitney U-tests. Corresponding author(s): Filip Swirski Last updated by author(s): Dec 20, 2018 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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